Aseem Anand
Papers
1
Total Citations
6
H-Index
1
About
Aseem Anand is a prominent researcher in the field of urologic oncology, with a specialized focus on improving the diagnostic accuracy and staging of prostate cancer. His key research areas encompass advanced molecular imaging, particularly the use of [18F]-fluorocholine (FCH) PET/CT for primary lymph node staging, as well as the integration of robotic-assisted surgical techniques with extended lymph node dissection. Anand's major contribution lies in critically evaluating the real-world clinical utility of FCH PET/CT, demonstrating through his most-cited 2021 retrospective study that while this imaging modality offers high specificity, its poor sensitivity limits its reliability for detecting lymph node metastases in intermediate and high-risk prostate cancer patients. This work, which has garnered 6 citations, provides essential evidence that challenges routine clinical recommendations for FCH PET/CT in primary staging, thereby guiding more judicious use of imaging resources. His findings underscore the need for more sensitive diagnostic tools and have informed ongoing debates about optimal staging protocols. Anand’s research is notable for its direct impact on surgical decision-making and patient management, offering a rigorous, data-driven perspective that helps clinicians avoid over-reliance on imperfect imaging techniques.
Research Focus
Key Achievements
Top Papers
- 1